Search Results for “antibody” – Page 62 – media

Moderna coronavirus vaccine shows ‘promising’ safety and immune response results in published Phase 1 study, but more research is needed

(CNN)A Covid-19 vaccine developed by the biotechnology company Moderna in partnership with the National Institutes of Health has been found to induce immune responses in all of the volunteers who received it in a Phase 1 study.
- Source: drugdu
- 457
- July 15, 2020
coronavirus vaccine Covid-19 vaccine
Fasenra Granted US Orphan Drug Designation for Eosinophilic Oesophagitis

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Fasenra (benralizumab) for the treatment of eosinophilic oesophagitis (EoE). EoE is a rare, chronic, inflammatory disease that occurs when eosinophils, a type of white blood cell, accumulate in the oesophagus causing injury and inflammation. The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US. About Fasenra Fasenra (benralizumab) is a monoclonal antibody that binds directly to the IL-5 receptor alpha on eosinophils and attracts natural killer cells to induce rapid and near-complete depletion of eosinophils via apoptosis (programmed cell death). Fasenra is AstraZeneca’s first respiratory biologic, now approved as an add-on maintenance treatment in severe eosinophilic asthma in the US, EU, Japan and other countries, with further regulatory reviews ongoing. In June 2019, the European Medicines ...
- Source: drugdu
- 763
- October 8, 2019
AstraZeneca Orphan Drug
Study Suggests Autistic Children could Communicate Better with Folinic Acid

Most autistic children struggle with communication and social skills. Though the causes are not completely understood there are indications of associations like women taking folate supplements during pre-conception and during gestation showed a lesser chance of having an offspring with autism spectrum disorder (ASD).
- Source: MedicalNewsBulletin
- 1,003
- August 16, 2018
autism Researches
Experimental Ebola Vaccines used During Ebola Outbreak in Congo

The health ministry of the DRC announced on 10 August that four new cases of Ebola virus were reported in eastern Democratic Republic of Congo.
- Source: Reuters
- 1,131
- August 14, 2018
Clinical Trials Ebola vaccine
Silencing Protein could Enhance Immunotherapy Efficacy in Cancer Tumors

Silencing an earlier known protein could hamper tumor development and increase the efficacy of immunotherapy treatments, researchers discovered at the Bloomberg~Kimmel Institute for Cancer Immunotherapy in the Johns Hopkins Kimmel Cancer Center.
- Source: MedicalXpress
- 745
- August 2, 2018
cancer immunotherapies Researches
HiFiBiO Receives New Funding, Inks R&D Deal with Takeda

HiFiBiO Therapeutics is aspiring to work on antibody therapies for different gastrointestinal diseases, cancers and other disorders by signing a pact with Japanese Pharma and biotech company Takeda.
- Source: FierceBiotech
- 759
- August 2, 2018
biotech Company Insight Takeda
Experimental Drug to Treat Alzheimer Disease

The condition of memory loss is termed as Alzheimer’s disease, affecting more than 5 million people and there is still no definite cure. A research team reported that an experimental drug could treat Alzheimer’s disease by slowing down the process of clear thinking and memory.
- Source: NBCNews
- 692
- August 1, 2018
Alzheimer's disease Researches
Interferon Status, Family History Linked to Autoimmune Connective Tissue Disease

A prospective, observational study published in Annals of the Rheumatic Diseases, showed that patients at risk of autoimmune connective tissue disease who evolved to definite disease had high interferon levels and a family history of autoimmune rheumatic disease, foreseeing a link between the interferon scores and disease progression.
- Source: MDEdge
- 517
- August 1, 2018
autoimmune autoimmune connective tissue disease Researches
Good Feedback for OMS721 Stem Cell Transplant Therapy

On 26 July 2018, Omeros Corporation announced that the European Medicines Agency's (EMA's) Committee for Orphan Medicinal Products (COMP) have positively recommended the lead human monoclonal antibody named OMS721 for stem cell transplantation therapy.
- Source: News Medical
- 850
- July 27, 2018
hematopoietic stem cells New Approvals
Mersana’s Lead Cancer ADC Held Up by FDA for Patient’s Death

The FDA held up Mersana’s top antibody-drug conjugate (ADC), XMT-1522 over safety issues following a patient’s death in phase 1 trial, causing a descent in the company’s shares.
- Source: FierceBiotech
- 200
- July 25, 2018
cancer Clinical Trial FDA

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.